SCHEMBL8843395

SCHEMBL8843395

CNCCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.54
GAA P10253 5/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 7/20 0.52
TSHR P16473 4/20 0.52
LMNA P02545 3/20 0.52
MAPK1 P28482 4/20 0.50
CYP1A2 P05177 3/20 0.50
HIF1A Q16665 3/20 0.50
BLM P54132 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
MEN1 O00255 2/20 0.50
CYP3A4 P08684 2/20 0.50
ATM Q13315 2/20 0.50
TP53 P04637 2/20 0.50
ALOX15 P16050 2/20 0.50
NFKB1 P19838 2/20 0.50
GMNN O75496 2/20 0.50
PMP22 Q01453 2/20 0.50
GABBR2 O75899 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8940787 0.98 GSR (0.56) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL9182795 0.86 GSR (0.61) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL284696 0.83 ALDH1A1 (0.63) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL17550780 0.83 GSR (0.53) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL9185815 0.81 GSR (0.56) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL9518040 0.80 GAA (0.61) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL9185437 0.80 GSR (0.54) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL9520969 0.80 GAA (0.54) GSRGAAKMT2AALDH1A1TSHR
SCHEMBL8844415 0.80 MAPT (0.66) ALDH1A1TSHRLMNAMAPK1CYP1A2
SCHEMBL7511206 0.80 GSR (0.62) GSRGAAKMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5633283-A Method for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1997-05-27 US claimed
US-5552439-A AMINOPHENOL DERIVATIVES ELI LILLY AND COMPANY (US) 1996-09-03 US claimed
EP-0722723-A2 Phenol derivatives for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP claimed
EP-0474403-B1 Method of treating inflammatory bowel disease LILLY CO ELI (US) 1995-05-10 EP claimed
US-5281623-A Administering amino substituted phenolic derivatives as antiinflammatory or antiarthritic agents ELI LILLY AND COMPANY (US) 1994-01-25 US claimed
EP-0474403-A1 Method of treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1992-03-11 EP claimed
US-5633283-A Method for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1997-05-27 US disclosed
US-5552439-A AMINOPHENOL DERIVATIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0722723-A2 Phenol derivatives for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0680755-A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy ELI LILLY AND COMPANY (US) 1995-11-08 EP disclosed
EP-0474403-B1 Method of treating inflammatory bowel disease LILLY CO ELI (US) 1995-05-10 EP disclosed
US-5393786-A Administering certain phenolic compounds ELI LILLY AND COMPANY (US) 1995-02-28 US disclosed
US-5281623-A Administering amino substituted phenolic derivatives as antiinflammatory or antiarthritic agents ELI LILLY AND COMPANY (US) 1994-01-25 US disclosed
US-5280046-A Using an amide containing phenol compound THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1994-01-18 US disclosed
EP-0500336-A1 Composition containing certain phenol and benzamide for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0476846-A2 Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy ELI LILLY AND COMPANY (US) 1992-03-25 EP disclosed
EP-0474403-A1 Method of treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1992-03-11 EP disclosed